Beaufort Announces Appointment of Bill Trembley as SVP, Chief Technology Officer

Beaufort, a global contract research organization (CRO), has announced the promotion of Bill Trembley to Senior Vice President, Chief Technology Officer (CTO). This appointment comes at a pivotal time for the company, supporting Beaufort’s continued growth as a leading MedTech CRO combined with expanding industry demand for technology-enabled solutions.

Vice President, Information Technology at Beaufort Bill Trembley

Bill brings over 25 years of experience in driving rapid technology innovation, optimizing operations, and guiding cross-functional teams to deliver measurable results. During his tenure at Beaufort, Bill has been a principal force in the advancement of Beaufort’s technical vision and strategy.

In addition to overseeing Beaufort’s existing data management and analytics operations, Bill will lead further integration of novel technology-solutions into clinical processes to better analyze trial data and provide timely insights on performance and trends. New technology platforms will support site selection and management for traditional, hybrid, and decentralized clinical trials (DCTs) with a focus on efficient trial start up and targeted subject enrollment to reach underserved and rare disease populations more effectively. Bill will also drive ongoing optimization of clinical operations including secure and efficient direct data capture and total program lifecycle management.

“In the dynamic landscape of clinical research, technology plays a crucial role in driving innovation and success,” said Clay Gill, President of Beaufort. “Bill’s new role reflects his outstanding track record of building and scaling teams, processes, and technologies that align with our commitment to providing comprehensive and innovative services.”

“I am excited to take on this expanded role within Beaufort,” said Bill Trembley. “With our experienced team and a client-centric approach, we are well-positioned to drive technological excellence and deliver innovative solutions. The emergence of AI and proliferation of new technologies within an evolving clinical research ecosystem provide even greater opportunities to positively impact our client’s work.”

This strategic move solidifies Beaufort’s commitment to staying at the forefront of technology in clinical research. Bill’s extensive experience and expanded role reflect the company’s dedication to fostering innovation, enhancing client solutions, and ensuring continued clinical research success.

View all news & insights